- Global pharmaceutical industry senior executive, PhD & MBA holder, professional who combines research, strategy and marketing expertise. Accomplished leader in senior R&D and commercial functions, Corporate and Japan affiliates.

- Extensive expertise in product value optimization/Lifecycle management, biosimilars, competitive intelligence, new products planning, business analysis, external innovation assessment, strategic marketing and integrated care solutions

- Multicultural and multilingual, international profile, strategic thinker, proven record of leading multi-country functions, handling organizational changes and operational challenges, and dealing with complex and multifaceted projects

Expertise: Competitive intelligence, marketing, strategic planning, science, R&D, business analysis, integrated care solutions, pharmaceutical industry

Sanofi S.A. is a French multinational healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur).